Efficacy of Exparel (TM) on Post-operative Pain After Laparoscopic Gastric Bypass Using Circular EEA Stapler
Launched by MATTHEW KROH · Jun 12, 2017
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
The study will include up to 150 patients, and will consist of two cohort. The study cohort will include 75 patients who receive intraoperative Exparel® injections at the incision locations in addition to our standard multimodality post-operative analgesia. The control arm will include 75 patients who meet inclusion criteria but receive standard 0.25% bupivacaine and our standard multimodality post-operative analgesia. Patients will be randomized by REDCap™ database system in collaboration with Cleveland Clinic Pharmacy to receive either Exparel® or the control medication (0.25% Bupivacaine...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • bariatric surgery patients
- • laparoscopic roux-en-y gastric bypass
- • use of EEA stapler anastomosis
- Exclusion Criteria:
- • age \<18 years
- • previous history of roux-en-y gastric bypass
- • patients undergoing other bariatric procedures
- • pre-operative opioid analgesics
About Matthew Kroh
Matthew Kroh is a dedicated clinical trial sponsor with extensive experience in advancing medical research and innovation. With a strong focus on developing groundbreaking therapies, he collaborates with leading researchers and institutions to facilitate clinical trials that aim to improve patient outcomes. His commitment to ethical practices, rigorous scientific standards, and patient safety drives the successful execution of trials across various therapeutic areas. Matthew Kroh's leadership and vision are instrumental in bridging the gap between laboratory discoveries and clinical application, ultimately contributing to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Alisan Fathalizadeh, M.D
Principal Investigator
Staff
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials